ST72社区型MRSA对万古霉素敏感性下降的遗传改变
本研究对一例万古霉素治疗失败的ST72社区型MRSA患者的两株同源菌株进行全基因组测序,发现五个非同义突变,并证实vraR单突变可提高vraSR mRNA表达和万古霉素MIC,导致异质性VISA表型及细胞壁增厚,与敏感性下降和治疗失败相关。
要点
- vraR(E127K)单突变可致万古霉素MIC升高和hetero-VISA表型。
- vraR突变株出现细胞壁增厚,经电镜确认。
- ST72社区型MRSA治疗失败需警惕万古霉素敏感性下降。
核心结论
- 基于基因组数据、分子实验及PAP和细胞壁分析,vraR单突变与MRSA对万古霉素敏感性下降及治疗失败相关。
研究设计与样本
- 对一例万古霉素和利福平治疗失败的ST72社区型MRSA患者的两株同源菌株进行全基因组测序追踪遗传改变。
主要发现
- 鉴定出五个非同义突变:rpoB(H481Y)、dprA(G196C)、femA(F92C)、vraR(E127K)和agrC(E391stop)。
- 将突变型vraR(E127K)导入万古霉素敏感金黄色葡萄球菌后,vraSR mRNA表达和万古霉素MIC升高,并出现hetero-VISA表型(经PAP/AUC确认)。
- 电镜显示携带突变vraR的菌株细胞壁增厚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We previously reported the first case of vancomycin treatment failure due to development of vancomycin-intermediate resistance in a patient with an MRSA of ST72, a community genotype in Korea. We investigated two isogenic MRSA strains from this patient, who experienced treatment failure with vancomycin and rifampicin. METHODS: We tracked the genetic alterations that confer reduced susceptibility to vancomycin on those two isogenic MRSA strains by WGS. RESULTS: Five non-synonymous mutations were identified, including rpoB (H481Y), dprA (G196C), femA (F92C), vraR (E127K) and agrC (E391stop). We further studied the role of a mutation of vraR in reduced susceptibility to vancomycin. Introduction of the mutated vraR (E127K) into a vancomycin-susceptible Staphylococcus aureus strain resulted in an increase in vraSR mRNA expression and vancomycin MIC and development of the hetero-VISA phenotype, which was confirmed by the population analysis profile (PAP)/AUC. Electron microscopy showed increased cell wall thickness in the strains with mutated vraR. CONCLUSIONS: Based on the genomic data, molecular experiments and PAP and cell wall analyses, we propose that a single mutation of vraR is associated with the reduced susceptibility to vancomycin in MRSA and further treatment failure.
引用
- Baek JY, Chung DR, Ko KS, et al. Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72. J Antimicrob Chemother. 2017. PMID: 28595277. doi:10.1093/jac/dkx175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。